Skip to content

DARETherapeutics - Developing a Next Generation Treatment for Wet AMD and DME

A novel target and antibody for stand-alone or combination therapeutics against conditions involving neovascularization

Published: 25th June 2019
DARETherapeutics - Developing a Next Generation Treatment for Wet AMD and DME
LightScribe, stock.adobe.com
Patents
  • Intellectual property rights are held by University of Southern Denmark (WO2014114298 and EP17199552.5).
IP Status
  • Patent application submitted
Seeking
  • Seeking investment
  • Development partner
  • Commercial partner